Clinician's Pocket Drug Reference 2008

More documents

Recommendations

Info

CLINICIAN’S POCKETDRUG REFERENCE<strong>2008</strong>EDITORSLeonard G. Gomella, MD, FACSSteven A. Haist, MD, MS, FACPAimee G. Adams, PharmDKelly M. Smith, PharmD, FASHPNew York Chicago San Francisco LisbonLondon Madrid Mexico City Milan New DelhiSan Juan Seoul Singapore Sydney Toronto
Copyright © <strong>2008</strong> by Leonard G. Gomella. All rights reserved. Manufactured in the United States ofAmerica. Except as permitted under the United States Copyright Act of 1976, no part of this publicationmay be reproduced or distributed in any form or by any means, or stored in a database or retrieval system,without the prior written permission of the publisher.0-07-159566-XThe material in this eBook also appears in the print version of this title: 0-07-149625-4.All trademarks are trademarks of their respective owners. Rather than put a trademark symbol after everyoccurrence of a trademarked name, we use names in an editorial fashion only, and to the benefit of thetrademark owner, with no intention of infringement of the trademark. Where such designations appearin this book, they have been printed with initial caps.McGraw-Hill eBooks are available at special quantity discounts to use as premiums and sales promotions,or for use in corporate training programs. For more information, please contact George Hoare, SpecialSales, at george_hoare@mcgraw-hill.com or (212) 904-4069.TERMS OF USEThis is a copyrighted work and The McGraw-Hill Companies, Inc. (“McGraw-Hill”) and itslicensors reserve all rights in and to the work. Use of this work is subject to these terms. Except aspermitted under the Copyright Act of 1976 and the right to store and retrieve one copy of the work, youmay not decompile, disassemble, reverse engineer, reproduce, modify, create derivative works basedupon, transmit, distribute, disseminate, sell, publish or sublicense the work or any part of it withoutMcGraw-Hill’s prior consent. You may use the work for your own noncommercial and personal use;any other use of the work is strictly prohibited. Your right to use the work may be terminated if you failto comply with these terms.THE WORK IS PROVIDED “AS IS.” McGRAW-HILL AND ITS LICENSORS MAKE NOGUARANTEES OR WARRANTIES AS TO THE ACCURACY, ADEQUACY OR COMPLETE-NESS OF OR RESULTS TO BE OBTAINED FROM USING THE WORK, INCLUDING ANYINFORMATION THAT CAN BE ACCESSED THROUGH THE WORK VIA HYPERLINK OROTHERWISE, AND EXPRESSLY DISCLAIM ANY WARRANTY, EXPRESS OR IMPLIED,INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY ORFITNESS FOR A PARTICULAR PURPOSE. McGraw-Hill and its licensors do not warrant orguarantee that the functions contained in the work will meet your requirements or that its operation willbe uninterrupted or error free. Neither McGraw-Hill nor its licensors shall be liable to you or anyone elsefor any inaccuracy, error or omission, regardless of cause, in the work or for any damages resultingtherefrom. McGraw-Hill has no responsibility for the content of any information accessed through thework. Under no circumstances shall McGraw-Hill and/or its licensors be liable for any indirect, incidental,special, punitive, consequential or similar damages that result from the use of or inability to use the work,even if any of them has been advised of the possibility of such damages. This limitation of liability shallapply to any claim or causewhatsoever whether such claim or cause arises in contract, tort or otherwise.DOI: 10.1036/0071496254
Page 4 and 5: ProfessionalWant to learn more?We h
Page 7 and 8: EDITORSLeonard G. Gomella, MD, FACS
Page 9 and 10: CONSULTING EDITORSVincenzo Berghell
Page 11 and 12: CONTRIBUTORSAmanda M. Ball, PharmDM
Page 13 and 14: PREFACEWe are pleased to present th
Page 15 and 16: MEDICATION KEYMedications are liste
Page 17 and 18: Medication KeyxvCategory ?: No data
Page 19 and 20: ABBREVIATIONS√: check or monitorA
Page 21 and 22: AbbreviationsInf: infusionInfxn: in
Page 23 and 24: AbbreviationsURI: upper respiratory
Page 25 and 26: CLASSIFICATION (Generic and common
Page 27 and 28: Last Classification 3PENICILLINSAmo
Page 29 and 30: Classification 5ANTINEOPLASTIC AGEN
Page 31 and 32: Classification 7Angiotensin-Convert
Page 33 and 34: Classification 9VasodilatorsAlprost
Page 35 and 36: Last Classification 11Miscellaneous
Page 37 and 38: Classification 13Miglitol (Glyset)N
Page 39 and 40: Classification 15Tobramycin, Ophtha
Page 41 and 42: Classification 17Infliximab (Remica
Page 43 and 44: Classification 19Hepatitis B Vaccin
Page 45 and 46: Classification 21Miscellaneous Ob/G
Page 47 and 48: Classification 23Guaifenesin (Robit
Page 49 and 50: Classification 25Orlistat (Xenical,
Page 51 and 52: GENERIC AND SELECTEDBRAND DRUG DATA
Page 53 and 54:
Acyclovir 29Acetazolamide (Diamox)
Page 55 and 56:
Alendronate 31PRN; 1 Rotacap inhale
Page 57 and 58:
Alprostadil, Intracavernosal 33somn
Page 59 and 60:
Amikacin 35Aluminum Hydroxide + Mag
Page 61 and 62:
Ammonium Aluminum Sulfate 37tiarrhy
Page 63 and 64:
Amprenavir 39membrane sterols, alte
Page 65 and 66:
Argatroban 41Antithymocyte Globulin
Page 67 and 68:
Atomoxetine 43Aspirin + Butalbital,
Page 69 and 70:
Azithromycin 45Atropine, ophthalmic
Page 71 and 72:
Beclomethasone 47mg PO tid; ↑ q3d
Page 73 and 74:
Bismuth subcitrate/metroindazole/te
Page 75 and 76:
Budesonide/formoterol 51q3mo; max 2
Page 77 and 78:
Calcium Salts 531-4 mg IM or IV q3-
Page 79 and 80:
Carteolol 55mg/5 mL SE: Drowsiness,
Page 81 and 82:
Cefoperazone 57lergy Disp: Inj: 500
Page 83 and 84:
Celecoxib 59IV/im q8-12h. Peds. 30-
Page 85 and 86:
Chlorothiazide 61dairy Contra: Not
Page 87 and 88:
Cimetidine 63pseudomembranous colit
Page 89 and 90:
Clindamycin 65glove”-type neuropa
Page 91 and 92:
Clozapine 67Clopidogrel (Plavix) Us
Page 93 and 94:
Cyanocobalamin 69dysfunction Contra
Page 95 and 96:
Cytarabine 71phosphoramide mustard,
Page 97 and 98:
Dapsone, topical 730.5 mg/d for 5 d
Page 99 and 100:
Deferasirox 75300 mg SE: ↑ glucos
Page 101 and 102:
Diazepam 77Dexamethasone, Ophthalmi
Page 103 and 104:
Digoxin 79250-500 mg qid Peds 6 mo
Page 105 and 106:
Diphtheria, Tetanus Toxoids 81Dinop
Page 107 and 108:
Dolasetron 83Peds. Cont IV inf of 2
Page 109 and 110:
Droperidol 85Doxepin, Topical (Zona
Page 111 and 112:
Efavirenz, emtricitabine, tenofovir
Page 113 and 114:
Epinephrine 89Action: LMW heparin;
Page 115 and 116:
Erythromycin 91sis fluids, anticoag
Page 117 and 118:
Esterified Estrogens + Methyltestos
Page 119 and 120:
Estrogen, Conjugated 95on product;
Page 121 and 122:
Ethinyl Estradiol & Norelgestromin
Page 123 and 124:
Famciclovir 99plant subdermally q3y
Page 125 and 126:
Ferrous Gluconate 101Fentanyl ionto
Page 127 and 128:
Fludrocortisone Acetate 103seen in
Page 129 and 130:
Fluticasone, Nasal 105Fluoxetine (P
Page 131 and 132:
Fosfomycin 107DVT or PE in combo w/
Page 133 and 134:
Gemfibrozil 109Galantamine (Razadyn
Page 135 and 136:
Glyburide 111Susp, ophth: Prednisol
Page 137 and 138:
Heparin 11350-100 mg (2.5-5 mL) PO
Page 139 and 140:
Hydrocodone & Acetaminophen 115pher
Page 141 and 142:
Hydroxyzine 117Hydrocortisone, Rect
Page 143 and 144:
Imipenem-Cilastatin 119may repeat X
Page 145 and 146:
Influenza Vaccine 121[D, ?] ↑ eff
Page 147 and 148:
Interferon beta 1a 123Alfa-2b (Intr
Page 149 and 150:
Isosorbide Dinitrate 125Iron Dextra
Page 151 and 152:
Labetalol 127matophytes & yeast; sh
Page 153 and 154:
Letrozole 129H. pylori Infxn, erosi
Page 155 and 156:
Levonorgestrel IUD 131Disp: Multido
Page 157 and 158:
Lisinopril 133Adults. EMLA cream, a
Page 159 and 160:
Lutropin Alfa 1351st-gen against gr
Page 161 and 162:
Medroxyprogesterone 137over 5-60 mi
Page 163 and 164:
Mesalamine 139tigue, arthralgia, Gu
Page 165 and 166:
Methotrexate 141Contra: SCr > 1.4 i
Page 167 and 168:
Metronidazole 1436-12 yrs* Action:
Page 169 and 170:
Mirtazapine 145intrauterine pregnan
Page 171 and 172:
Moxifloxacin 147D 2nd & 3rd tri), ?
Page 173 and 174:
Naltrexone 149Caution: [C,?/- ] Eld
Page 175 and 176:
Neomycin & Polymyxin B 151Nefazodon
Page 177 and 178:
Nicotine Gum 153surgery Contra: NSA
Page 179 and 180:
Norepinephrine 155Nitrofurantoin (M
Page 181 and 182:
Omega-3 fatty acid 157dostatin LAR
Page 183 and 184:
Orphenadrine 159Disp: 28-d cycle pi
Page 185 and 186:
Oxycodone & Acetaminophen 161membra
Page 187 and 188:
Pamidronate 163Paclitaxel (Taxol, A
Page 189 and 190:
Pemetrexed 165constipation Notes: C
Page 191 and 192:
Pentobarbital 167synth. Spectrum: P
Page 193 and 194:
Phenylephrin, oral 169mia, constipa
Page 195 and 196:
Pirbuterol 171Pimecrolimus (Elidel)
Page 197 and 198:
Potassium Supplements 173Contra: GI
Page 199 and 200:
Procarbazine 175transmission modula
Page 201 and 202:
Protamine 177erides w/ extended dos
Page 203 and 204:
Ranibizumab 179Dose: 10-80 mg PO da
Page 205 and 206:
Rifaximin 181each dose (ECC 2005) C
Page 207 and 208:
Ropinirole 183or ergot alkaloids du
Page 209 and 210:
Selenium Sulfide 185chemo/RT Disp:
Page 211 and 212:
Sitagliptin 187Silver Nitrate (Dey-
Page 213 and 214:
Sorafenib 189izer Dose: Adults. 2-6
Page 215 and 216:
Steroids, Systemic 191Stavudine (Ze
Page 217 and 218:
Sulfacetamide 193mg/mL (1-g vial) S
Page 219 and 220:
Tamoxifen 195Sunitinib (Sutent) Use
Page 221 and 222:
Tenecteplase 197Telmisartan (Micard
Page 223 and 224:
Tetracycline 199Terconazole (Terazo
Page 225 and 226:
Ticarcillin/Potassium Clavulante 20
Page 227 and 228:
Tobramycin & Dexamethasone Ophthalm
Page 229 and 230:
Trandolapril 205Topiramate (Topamax
Page 231 and 232:
Trifluridine Ophthalmic 207& oint 1
Page 233 and 234:
Valproic Acid 209Triptorelin (Trels
Page 235 and 236:
Vinblastine 211Vasopressin [Antidiu
Page 237 and 238:
Ziconotide 213Warfarin (Coumadin) U
Page 239 and 240:
Zoster vaccine, live 215Initial 2.5
Page 241 and 242:
NATURAL and HERBAL AGENTSThe follow
Page 243 and 244:
Melatonin 219tablets or capsules or
Page 245 and 246:
Unsafe Herbs with Known Toxicity 22
Page 247 and 248:
Tables223Copyright © 2008 by Leona
Page 249 and 250:
6-8 y/48-59 lb/ 4 tab 2 tsp 2 cap/t
Page 251 and 252:
Tables 227TABLE 3Comparison of Syst
Page 253 and 254:
229Fluocinolone acetonide 0.2% Syna
Page 255 and 256:
Tables 231TABLE 5Comparison of Insu
Page 257 and 258:
233Lo/Ovral 21, 28 (Wyeth) Ethinyl
Page 259 and 260:
Tri-Sprintec (Barr) Ethinyl estradi
Page 261 and 262:
Tables 237TABLE 8Tetanus Prophylaxi
Page 263 and 264:
Tables 239TABLE 10Antiarrhythmics:
Page 265 and 266:
Tables 241TABLE 11 (continued)Cytoc
Page 267 and 268:
TABLE 13Composition of selected mul
Page 269 and 270:
Therapeutic 100 100 200 NA 150 200
Page 271 and 272:
Therapeutic 4 3 25 50 100 100 100
Page 273 and 274:
IndexAbacavir (Ziagen), 4, 27Abatac
Page 275 and 276:
Index 251Altabax (retapamulin), 4,
Page 277 and 278:
Index 253Atenolol and chlorthalidon
Page 279 and 280:
Index 255Bupropion (Wellbutrin, Zyb
Page 281 and 282:
Index 257Citalopram (Celexa), 10, 6
Page 283 and 284:
Index 259Dacarbazine (DTIC), 6, 72D
Page 285 and 286:
Index 261Dobutamine (Dobutrex), 8,
Page 287 and 288:
Index 263Estinyl (ethinyl estradiol
Page 289 and 290:
Index 265Flutamide (Eulexin), 5, 10
Page 291 and 292:
Index 267Human papillomavirus (type
Page 293 and 294:
Index 269Ipecac syrup, 1, 124Ipratr
Page 295 and 296:
Index 271Lithobid (lithium carbonat
Page 297 and 298:
Index 273Microgestin Fe, 233tMicro-
Page 299 and 300:
Index 275NeOral (cyclosporine), 71N
Page 301 and 302:
Index 277Oxacillin (Bactocill, Pros
Page 303 and 304:
Index 279Pneumococcal vaccine, poly
Page 305 and 306:
Index 281Quixin and Iquix ophthalmi
Page 307 and 308:
Index 283Serevent (salmeterol), 23S
Page 309 and 310:
Index 285Telmisartan (Micardis), 7,
Page 311 and 312:
Index 287Tri-Sprintec, 235tTrivora,
Page 313 and 314:
Index 289Yasmin, 234tYaz, 235tYohim
Page 315:
TIPS FOR SAFE PRESCRIPTION WRITING*
show all

Clinician's Pocket Drug Reference 2008

Create successful ePaper yourself

Delete template?

Save as template?